Wells Fargo’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-167
| Closed | -$1K | – | 7161 |
|
2022
Q1 | $1K | Hold |
167
| – | – | ﹤0.01% | 6511 |
|
2021
Q4 | $1K | Hold |
167
| – | – | ﹤0.01% | 6516 |
|
2021
Q3 | $2K | Hold |
167
| – | – | ﹤0.01% | 6262 |
|
2021
Q2 | $2K | Hold |
167
| – | – | ﹤0.01% | 6223 |
|
2021
Q1 | $3K | Hold |
167
| – | – | ﹤0.01% | 6227 |
|
2020
Q4 | $3K | Hold |
167
| – | – | ﹤0.01% | 5924 |
|
2020
Q3 | $2K | Hold |
167
| – | – | ﹤0.01% | 5799 |
|
2020
Q2 | $2K | Hold |
167
| – | – | ﹤0.01% | 5730 |
|
2020
Q1 | $1K | Hold |
167
| – | – | ﹤0.01% | 5746 |
|
2019
Q4 | $1K | Hold |
167
| – | – | ﹤0.01% | 5821 |
|
2019
Q3 | $1K | Buy |
+167
| New | +$1K | ﹤0.01% | 5814 |
|
2017
Q3 | – | Sell |
-15
| Closed | – | – | 5995 |
|
2017
Q2 | $0 | Hold |
15
| – | – | ﹤0.01% | 5956 |
|
2017
Q1 | $0 | Hold |
15
| – | – | ﹤0.01% | 5962 |
|
2016
Q4 | $1K | Hold |
15
| – | – | ﹤0.01% | 5756 |
|
2016
Q3 | $1K | Sell |
15
-1,780
| -99% | -$119K | ﹤0.01% | 5755 |
|
2016
Q2 | $102K | Sell |
1,795
-168
| -9% | -$9.55K | ﹤0.01% | 4649 |
|
2016
Q1 | $114K | Sell |
1,963
-167
| -8% | -$9.7K | ﹤0.01% | 4583 |
|
2015
Q4 | $125K | Sell |
2,130
-4,106
| -66% | -$241K | ﹤0.01% | 4590 |
|
2015
Q3 | $357K | Sell |
6,236
-160
| -3% | -$9.16K | ﹤0.01% | 4027 |
|
2015
Q2 | $578K | Buy |
6,396
+504
| +9% | +$45.5K | ﹤0.01% | 3904 |
|
2015
Q1 | $567K | Buy |
5,892
+356
| +6% | +$34.3K | ﹤0.01% | 3793 |
|
2014
Q4 | $484K | Sell |
5,536
-906
| -14% | -$79.2K | ﹤0.01% | 3880 |
|
2014
Q3 | $588K | Sell |
6,442
-2,677
| -29% | -$244K | ﹤0.01% | 3749 |
|
2014
Q2 | $1.05M | Buy |
9,119
+1,581
| +21% | +$182K | ﹤0.01% | 3444 |
|
2014
Q1 | $913K | Buy |
7,538
+157
| +2% | +$19K | ﹤0.01% | 3524 |
|
2013
Q4 | $928K | Buy |
7,381
+419
| +6% | +$52.7K | ﹤0.01% | 3440 |
|
2013
Q3 | $757K | Buy |
6,962
+1,389
| +25% | +$151K | ﹤0.01% | 3501 |
|
2013
Q2 | $470K | Buy |
+5,573
| New | +$470K | ﹤0.01% | 3696 |
|